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Human glomeruli with intermediate (i-GS) and advanced (GS)
sclerotic lesions as well as the normal control (Nor) were captured
from laser microdissection, digested by trypsin and subjected to
shotgun LC-MS/MS analysis (LTQ-Orbitrap XL). The label-free
quantiﬁcation was performed using the Normalized Spectral Index
(SIN) to assess the relative molar concentration of each protein
identiﬁed in a sample. All the experimental data are shown in this
article. The data is associated to the research article submitted to
Journal of Proteomics [1].
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More speciﬁc
subject areaLabel-free quantitative proteomicsType of data a. Excel datasheets with peptide and protein identiﬁcations in each sample.
b. Excel datasheet with Normalized Spectral Index (SIN) of the proteins identiﬁed in each sample.
c. Venn diagrams for peptide/protein identiﬁcations in each group.
d. Graphs for comparison of SIN values between the sample groups.How data was
acquiredMS/MS data acquired from LTQ-Orbitrap XL (Thermo Scientiﬁc) combined with nanoscale C18
reversed phase liquid chromatography (DiNa-A, KYA technologies).
Peptide/protein identiﬁcation results exported from Mascot.Data format .xlsx (peptide/protein identiﬁcations and SIN values)
.PDF (Venn diagrams and comparison of SIN values)Experimental factors No sample pretreatment applied
Experimental
featuresHuman glomerular sections were collected by laser microdissection and digested by trypsin. The
peptide sample was puriﬁed with StageTips C18 before analyzed by LC-MS/MS in triplicates.Data source location Niigata City, Japan
Data accessibility All the experimental data are available in this article.Value of the data In-depth proteomic proﬁles provide comprehensive protein composition of human sclerotic
glomeruli. SIN-based label-free quantitative datasets are useful to explore the key biological events which
would be critically involved in the progression of human glomerulosclerosis. Detailed information on peptide-spectrum matches and ion intensities for spectral queries enables
further bioinformatic analysis.1. Data, experimental design, materials and methods
We aimed to characterize human glomeruli with intermediate and advanced sclerotic lesions by
label-free quantitative proteomic approach in combination with laser microdissection. Macroscopi-
cally normal kidney tissues were obtained from patients who underwent nephrectomy due to
urological cancers. Sclerotic glomeruli, which were excluded from speciﬁc renal diseases and assumed
to be aging-related, were divided into two groups, intermediate (i-GS) and advanced (GS) sclerosis, as
well as the normal control (Nor). Glomerular sections (10 μm–thick, ﬁxed by methyl–Carnoy) were
collected by laser microdissection (50 sections/sample, 3 samples/group from 3 patients). The detailed
information on patients and specimens are given in the associated article submitted to Journal of
Proteomics [1].
Each glomerular sample was directly digested with 15 μl of activated trypsin solution (20 ng/μl) at
37 1C overnight. After trypsin digestion, 1 μl of 50% triﬂuoacetic acid (TFA) was added to the peptide
mixture to quench the trypsin activity. Peptides were eluted and puriﬁed using StageTips C18 (Thermo
Scientiﬁc) according to the manual instructions [2]. Brieﬂy, the C18 tips were ﬁrstly activated with
solvent A (80% acetonitrile, 5% formic acid) and re-equilibrated with solvent B (5% formic acid) before
sample loading. Then the peptides were eluted twice with 20 μl of solvent A. Finally, the peptide
eluate was dehydrated in a Speedvac for dryness and stored at 30 1C until LC-MS/MS analysis. We
estimated that around 1 μg of peptides could be extracted from one sample according to BCA assay. As
the peptide yield is very limited, we did not perform BCA assay for the samples which were analyzed
by LC-MS/MS. All peptides extracted from each sample were directly analyzed in triplicate.
Each peptide sample was solubilized in the sample solution (2% acetonitrile, 0.1% formic acid) and
measured in triplicates by LTQ-Orbitrap XL (Thermo Scientiﬁc) combined with nanoscale C18 reversed
Fig. 1. Reproducibility of protein and peptide identiﬁcations by LC-MS/MS analysis in three biological duplicates of each group.
A, B and C. Venn diagrams for the proteins identiﬁed in three biological samples of the groups Nor, i-GS and GS, respectively. D,
E and F. Venn diagrams for the peptides identiﬁed in three biological samples of the groups Nor, i-GS and GS, respectively.
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separation column (75 μm100 mm, particle size of 3 μm, pore size of 120 Å) and eluted with a
120 min mobile phase gradient at the ﬂow rate of 300 nl/min. MS survey scan (m/z 350–1600,
resolution 60,000) was acquired in the Orbitrap and the ﬁve most intensive precursor ions were
fragmented in linear ion trap. The dynamic exclusion time was set to 60 s. The MS/MS spectral data
obtained from the triplicate measurements for each sample were merged by Mascot Daemon software
(Matrix Science) and then searched against UniProtKB/Swiss-Prot human database (release 2014_04)
using the Mascot search engine (Version 2.3.01). The parameters for protein identiﬁcation used were
as follows: peptide tolerance, 10 ppm; MS/MS tolerance, 0.8 Da; ﬁxed modiﬁcation, none; variable
modiﬁcation, oxidation on methionine (M), histidine (H), and tryptophan (W); No. of missed trypsin
cleavages, 2; signiﬁcance threshold po0.01; protein scoring, MudPIT (multidimensional protein
identiﬁcation technology). Peptide FDR was controlled o1%. Protein hits with two matched peptides
were considered as conﬁdent identiﬁcations. To eliminate protein redundancy, proteins with different
accession numbers but same gene name were grouped and the protein with the highest score was
selected to generate the ﬁnal protein identiﬁcation list. The reproducibility of peptide and protein
identiﬁcations among three samples in each group are examined by Venn diagrams (Fig. 1).
The label-free quantitative proteomic analysis was performed using Normalized Spectral Index
(SIN) based on the previous description [3,4]. This label-free quantitative value, SIN, consists of
multiple MS abundance features for a given protein hit: peptide count, spectral count for all assigned
peptides, total ion intensities of all matched MS/MS spectra, and protein length (number of amino
acids). Firstly, the abundance of a protein is calculated as the cumulative ion intensities of all assigned
MS/MS spectra for a protein hit. Secondly, the intensity of the protein is normalized by dividing its
Fig. 2. Label-free quantiﬁcation (Normalized Spectra Index, SIN) and comparison of the proteins identiﬁed in i-GS and Nor. A.
The protein distribution pattern in the whole SIN dynamic range. The narrower SIN range outlined with a dotted line is
magniﬁed in B. B. Enlarged image for the proteins in the narrower SIN range in A. The representative proteins increased and
decreased in GS in the ﬁelds 1 and 2 are listed below the symbol legend.
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Fig. 3. Proteins involved in extracellular matrix construction are signiﬁcantly increased in glomerular sclerosis while podocyte
featured proteins are decreased. A. Extracellular matrix proteins. B. Podocyte slit diaphragm and cytoskeleton proteins.
COL12A1, collagen, type XII, alpha 1; COL4A1, collagen, type IV, alpha 1; COL4A2, collagen, type IV, alpha 2; COL6A1, collagen,
type VI, alpha 1; COL6A2, collagen, type VI, alpha 2; COL6A3, collagen, type VI, alpha 3; COL7A1, collagen, type VII, alpha 1;
LAMA5, laminin, alpha 5; LAMB2, laminin, beta 2 (laminin S); LAMC1, laminin, gamma 1; BGN, biglycan; LUM, lumican; VTN,
vitronectin; POSTN, periostin; ACTN4, actinin, alpha 4; EZR, ezrin; PODXL, podocalyxin; NPHS2, podocin; SYNPO, synaptopodin;
CLIC4, chloride intracellular channel protein 4; TJP1, tight junction protein 1; CTTN, cortactin; NPHS1, Nephrin. Results are
indicated as Mean7SD. *po0.05; **po0.01; ***po0.001.
Y. Zhang et al. / Data in Brief 4 (2015) 180–185184intensity by the total intensities of all proteins identiﬁed in the dataset. Thirdly, the normalized
intensity of this protein is divided by the protein length to obtain the relative molar concentration of
this protein in the sample. In this study, we grouped the identiﬁed proteins according to their gene
names, then ﬁltered out the duplicate spectra occurring in the same group, and ﬁnally calculated the
SIN value for each protein group using the following formula:
ðSINÞj¼
SIj=
Pn
i ¼ 1 SIi
Lj(SIN)j: Normalized spectral index of the protein group with gene name j.
SIj: Total ion intensities of MS/MS spectra assigned to the protein group with gene name j.Pn
i ¼ 1 SIi:Total ion intensities of all the protein groups identiﬁed in a given sample.
Lj:The length of the protein having the highest protein score in the group with gene name j.
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detailed peptide/protein identiﬁcation in each sample, e.g. peptide-spectrum matches, protein hits,
and ion intensities of MS/MS spectral queries, etc. are shown in Supplementary Table 1. In this table,
the proteomic data necessary for SIN calculation are highlighted in blue. The SIN values of identiﬁed
proteins among three samples in each group and the results of statistical analysis are shown in
Supplementary Table 2.
The SIN values of each protein in the three samples of the groups i-GS and Nor were summed,
compared and plotted in Fig. 2. The data suggest that complement components (C4, C5, C6, C7, C8, C9) and
their regulators (CFH, CFHR1, vitronectin, clusterin) are at least twice increased in i-GS than Nor. More
importantly, the over-expression of complement pathway indicates a general up-going tendency from i-
GS to GS (see Ref. [1], Figs. 3 and 4). Additionally, diverse extracellular matrix proteins are found
predominantly accumulated in sclerotic glomeruli whereas various podocyte proteins important to slit
diaphragm and cytoskeletal integrity are dramatically reduced or lost (Fig. 3).Funding sources
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